SYMMETREL AMANTADINE HCL Trademark
Trademark Overview
On Wednesday, September 23, 1998, a trademark application was filed for SYMMETREL AMANTADINE HCL with the United States Patent and Trademark Office. The USPTO has given the SYMMETREL AMANTADINE HCL trademark a serial number of 75557230. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, August 11, 2002. This trademark is owned by Endo Pharmaceuticals Inc.. The SYMMETREL AMANTADINE HCL trademark is filed in the Paper & Printed Material Products and Education & Entertainment Services categories with the following description:
patient information brochures, pamphlets, booklets and leaflets on the subject of the symptoms and treatment of influenza A and Parkinson's disease
providing educational information via telephone and computer networks on the subject of the symptoms and treatment of influenza A and Parkinson's disease
General Information
Serial Number | 75557230 |
Word Mark | SYMMETREL AMANTADINE HCL |
Filing Date | Wednesday, September 23, 1998 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Sunday, August 11, 2002 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3T07 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 18, 1999 |
Trademark Statements
Disclaimer with Predetermined Text | "AMANTADINE HCL" |
Goods and Services | patient information brochures, pamphlets, booklets and leaflets on the subject of the symptoms and treatment of influenza A and Parkinson's disease |
Goods and Services | providing educational information via telephone and computer networks on the subject of the symptoms and treatment of influenza A and Parkinson's disease |
Classification Information
International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
Class Status Code | 6 - Active |
Class Status Date | Monday, November 9, 1998 |
Primary Code | 016 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Monday, November 9, 1998 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Endo Pharmaceuticals Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Chadds Ford, PA 19317 |
Party Name | Endo Pharmaceuticals Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Chadds Ford, PA 19317 |
Trademark Events
Event Date | Event Description |
Friday, March 7, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Thursday, January 31, 2002 | EXTENSION 5 GRANTED |
Friday, January 11, 2002 | EXTENSION 5 FILED |
Friday, July 27, 2001 | EXTENSION 4 GRANTED |
Monday, July 16, 2001 | EXTENSION 4 FILED |
Sunday, February 18, 2001 | EXTENSION 3 GRANTED |
Tuesday, December 26, 2000 | EXTENSION 3 FILED |
Thursday, September 28, 2000 | EXTENSION 2 GRANTED |
Monday, August 7, 2000 | EXTENSION 2 FILED |
Friday, January 14, 2000 | EXTENSION 1 GRANTED |
Friday, January 14, 2000 | EXTENSION 1 FILED |
Tuesday, August 10, 1999 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, May 18, 1999 | PUBLISHED FOR OPPOSITION |
Friday, April 16, 1999 | NOTICE OF PUBLICATION |
Friday, February 5, 1999 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, February 4, 1999 | ASSIGNED TO EXAMINER |